5 from 5i: Are thematic funds worthy of the hype or a risky distraction?
Weekly stock market update & five stock related articles we thought were a must-read this...
Stock Research
Knight Therapeutics has been a name that has tested investors' patience. While its no debt and high cash offer plenty of protection to the...
Operating in a stagnant growth industry is hard enough, and with a large cash balance and no M&A activity over the past decade made Winpak's...
The strategy of "simplicity is the best" is far too forgotten in the investment world. In this blog, we talk about three stocks that are at...
Looking for more? Sign up for a FREE 14 day trial !
We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; unbiased stocks research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!
More from 5i Research
Updates from 5i Research: Market and Portfolio Updates and New Report - August 17, 2021
New Report We have initiated coverage on Andlauer Healthcare Group (AND). This is a...
Reliable Retirement Streams
Five dividend stocks we think can bear some of your retirement expenses in the long-run